title: Screening for new primary cancers in cancer survivors compared to non-cancer controls: a systematic review and meta-analysis.
abstract: OBJECTIVE
  The goal of this study was to synthesize evidence comparing cancer screening receipt between cancer survivors and non-cancer controls by conducting a systematic review and meta-analysis.
  
  
  METHODS
  We searched PubMed, EMBASE, and CINAHL databases from inception through April 1, 2010 using search terms related to cancer, survivorship, and cancer screening. Studies were included if they reported a comparison of cancer screening receipt between cancer survivors and non-cancer controls. We performed a meta-analysis on the effect of cancer survivorship on breast, cervical, colorectal, and prostate cancer screening receipt.
  
  
  RESULTS
  Our search strategy identified 1,778 titles, of which 20 met our inclusion/exclusion criteria. In our meta-analyses, cancer survivors were more likely to be screened for breast, cervical, colorectal, and prostate cancer than non-cancer controls (pooled odds ratio, 1.27; 95 % CI, 1.19-1.36). We observed significant heterogeneity between studies, most of which remained unexplained after subgroup and sensitivity analyses. Important contextual factors, such as how screening programs operate, were not reported in the primary literature. Many cancer survivors (along with non-cancer controls) still did not receive cancer screening.
  
  
  CONCLUSIONS
  Compared with non-cancer controls, cancer survivors receive more frequent screening for new primary breast, cervical, colorectal, and prostate cancers. Future research should seek to determine whether increased uptake of cancer screening is associated with improved outcomes during cancer survivorship.
  
  
  CONCLUSIONS
  Our systematic review and meta-analysis demonstrated that cancer survivors received more frequent screening for second primary breast, cervical, colorectal, and prostate cancers than non-cancer controls. As many cancer survivors are at an increased risk of developing a second primary cancer, future research should seek to determine whether this increased uptake of cancer screening in cancer survivors leads to improved outcomes during cancer survivorship.
authors: Department of Community Health and Epidemiology, Dalhousie University, 5790 University Ave, Halifax, NS, Canada.
authors: Mark
authors: M
authors: Corkum
authors: Jill A
authors: JA
authors: Hayden
authors: George
authors: G
authors: Kephart
authors: Robin
authors: R
authors: Urquhart
authors: Coralynne
authors: C
authors: Schlievert
authors: Geoffrey
authors: G
authors: Porter
mesh_terms: D016022:Case-Control Studies; D055088:Early Detection of Cancer; D005260:Female; D006284:Health Plan Implementation / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D016609:Neoplasms, Second Primary / Q000175:diagnosis* / Q000453:epidemiology; D017741:Survivors / Q000706:statistics & numerical data*
references: JAMA. 2009 Jan 28;301(4):404-14
references: 19176442
references: J Cancer Surviv. 2007 Mar;1(1):17-26
references: 18648941
references: Arch Intern Med. 1994 Sep 26;154(18):2058-68
references: 8092910
references: Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):759-67
references: 10498394
references: J Fam Pract. 1994 Feb;38(2):166-71
references: 8308509
references: BMC Cancer. 2009 Oct 20;9:373
references: 19843324
references: Eur J Cancer. 2008 Jan;44(2):195-204
references: 18035534
references: Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):468-76
references: 18234434
references: Biol Blood Marrow Transplant. 2010 Feb;16(2):207-14
references: 19781657
references: Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2020-6
references: 17057028
references: J Cancer Surviv. 2010 Mar;4(1):1-14
references: 19882379
references: J Fam Pract. 1995 Feb;40(2):162-71
references: 7654272
references: J Clin Oncol. 2003 Apr 15;21(8):1447-51
references: 12697865
references: J Cancer Surviv. 2009 Mar;3(1):12-20
references: 19224371
references: Cancer. 2004 Feb 1;100(3):631-40
references: 14745882
references: Implement Sci. 2011 Sep 29;6:112
references: 21958602
references: Cancer Detect Prev. 2006;30(1):52-7
references: 16455209
references: Am J Obstet Gynecol. 2008 Jan;198(1):86.e1-8
references: 18166316
references: Laeknabladid. 2000 Feb;86(2):108-14
references: 17018914
references: BMC Cancer. 2011 Feb 23;11:83
references: 21342533
references: Cancer. 2004 Oct 15;101(8):1712-9
references: 15386307
references: Ann Intern Med. 2006 Mar 21;144(6):427-37
references: 16549855
references: Gut. 2002 May;50(5):647-52
references: 11950810
references: Br J Cancer. 2010 Mar 30;102(7):1085-90
references: 20234361
references: Ann Intern Med. 2010 Apr 6;152(7):444-55; W144-54
references: 20368650
references: Oncol Nurs Forum. 2008 Mar;35(2):E12-22
references: 18321824
references: J Natl Cancer Inst. 1997 Oct 1;89(19):1429-39
references: 9326912
references: Can Fam Physician. 2012 Sep;58(9):980-6
references: 22972732
references: J Clin Oncol. 2005 Dec 1;23(34):8884-93
references: 16314649
references: J Clin Oncol. 2009 Mar 1;27(7):1054-61
references: 19164212
references: BMC Health Serv Res. 2012 Sep 13;12:316
references: 22973899
references: J Cancer Educ. 2003 Winter;18(4):230-6
references: 14766334
references: J Gen Intern Med. 2009 Apr;24(4):469-74
references: 19156470
references: J Chronic Dis. 1970 Dec;23(7):455-68
references: 26309916
references: Obstet Gynecol. 2009 Apr;113(4):790-795
references: 19305321
references: Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):793-8
references: 11440965
references: J Gen Intern Med. 2009 Nov;24 Suppl 2:S487-90
references: 19838855
references: Phys Ther. 2008 Feb;88(2):156-75
references: 18073267
references: Am J Prev Med. 2005 May;28(4):351-6
references: 15831340